Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022

Title: Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022
Authors: Lourenco, Olga; Cvetkovski, Biljana; Kritikos, Vicky; House, Rachel; Scheire, Sophie; Costa, Elisio M.; Fonseca, Joao A.; Menditto, Enrica; Bedbrook, Anna; Bialek, Slawomir; Briedis, Vitalis; Boussery, Koen; Canonica, G. Walter; Haahtela, Tari; Kuna, Piotr; Mullol, Joaquim; Orlando, Valentina; Samolinski, Boleslaw; Wallace, Dana; Duggan, Catherine; Paulino, Ema; Pinto, Goncalo S.; Soderlund, Lars-Ake; Bousquet, Jean; Bosnic-Anticevich, Sinthia
Contributors: HUS Inflammation Center; Department of Dermatology, Allergology and Venereology; HUS Shared Group Services; Clinicum; University of Helsinki
Publisher Information: John Wiley & Sons Ltd.
Publication Year: 2022
Collection: Helsingfors Universitet: HELDA – Helsingin yliopiston digitaalinen arkisto
Subject Terms: allergic rhinitis; community pharmacy; pharmacist; QUALITY-OF-LIFE; ASTHMA; EPIDEMIOLOGY; IMPACT; General medicine; internal medicine and other clinical medicine
Description: Background Allergic rhinitis (AR) management requires a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians. Methods Allergic Rhinitis and its Impact on Asthma (ARIA) first published a reference document on the pharmacist's role in allergic rhinitis management in 2004. Several guidelines were developed over the past 20 years improving the care of allergic rhinitis patients through an evidence-based, integrated care approach. Results This ARIA/EAACI/FIP Position Paper is based on the latest ARIA in the Pharmacy guidelines and provides: (a) a structured approach to pharmacists identifying people with AR and/or allergic conjunctivitis as well as those at risk of poor disease control; (b) an evidence-based clinical decision support tool for optimising the management of allergic rhinitis in the community pharmacy; and (c) a framework of referral to the physician. Conclusion This document is not intended to be a mandatory standard of care but is provided as a basis for pharmacists and their staff to develop relevant local standards of care for their patients, within their local practice environment. Pharmacy care varies between countries, and the guide should be adapted to the local situation. ; Peer reviewed
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: Open access funding enabled and organized by Projekt DEAL.; https://hdl.handle.net/10138/350384; 000863848300001
Availability: https://hdl.handle.net/10138/350384
Rights: cc_by ; info:eu-repo/semantics/openAccess ; openAccess
Accession Number: edsbas.E96EA03B
Database: BASE